<![CDATA[<![CDATA[]]]]>]]>Meet 3 Men on the Front Lines of HIV Treatments | Johnson & Johnson<![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[<![CDATA[]]]]]]>]]]]>]]><![CDATA[<![CDATA[]]]]>]]><!–[if lte IE 9 Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari. alt Left to right: Joss J. De Wet, M.D., Johnson & Johnson’s Brian Woodfall, M.D., and artist Tiko Kerr Andy Meyers at M3 Creative Share

Did you like watching this video? Click the heart to show your love.

35

Innovation

Share

Did you like watching this video? Click the heart to show your love.

35

Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. Watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video, filmed for AIDS 2022, the annual International AIDS Conference.

By Johnson & JohnsonJuly 28, 2022

Did you like watching this video? Click the heart to show your love.

35

Read about the many ways Johnson & Johnson is working to #makeHIVhistory.

This site uses cookies as described in our Cookie Policy. Please click the “Accept” button or continue to use our site if you agree to our use of cookies.

Reject Accept

<![CDATA[<![CDATA[<![CDATA[]]]]]]>]]]]>]]><![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]>

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.

Source